GURUFOCUS.COM » STOCK LIST » Energy » Oil & Gas » Renergen Ltd (ASX:RLT) » Definitions » Capital Expenditure

Renergen (ASX:RLT) Capital Expenditure : A$-18.98 Mil (TTM As of Aug. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Renergen Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Renergen's cash flow for capital expenditures for the six months ended in Aug. 2024 was A$-7.64 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Aug. 2024 was A$-18.98 Mil.


Renergen Capital Expenditure Historical Data

The historical data trend for Renergen's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renergen Capital Expenditure Chart

Renergen Annual Data
Trend Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24
Capital Expenditure
Get a 7-Day Free Trial -31.68 -16.26 -28.14 -35.72 -24.49

Renergen Semi-Annual Data
Aug16 Feb17 Aug17 Feb18 Aug18 Feb19 Aug19 Feb20 Aug20 Feb21 Aug21 Feb22 Aug22 Feb23 Aug23 Feb24 Aug24
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -23.78 -13.35 -13.39 -11.34 -7.64

Renergen Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Aug. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-18.98 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Renergen Business Description

Industry
Traded in Other Exchanges
Address
25 Minerva Avenue, Sandton Gate, Glenadrienne, Sandton, ZAF, 2196
Renergen Ltd is an investment holding company focused on the alternative and renewable energy sectors in South Africa and sub-Saharan Africa. Its reportable segments are the Corporate Head office where all investment decisions are made; Tetra4 which explores, produces, and sells LNG in South Africa; Cryovation which has developed Cryo-VaccTM technology, and enables the safe transportation of vaccines and biologics at extremely low temperatures without the need for electrical power; and the Renergen U.S segment which assists with various fundraising and business development activities of the Group in the U.S market. The majority of the company's revenue is generated from the Tetra4 segment.

Renergen Headlines

No Headlines